{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:37:13Z","timestamp":1786981033376,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Glycoconj J"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The capsular polysaccharide of the human pathogen Group B\n                    <jats:italic>Streptococcus<\/jats:italic>\n                    is a key virulence factor and vaccine candidate that induces protective antibodies when conjugated to carrier proteins. It consists of long polymeric chains of oligosaccharide repeating units, and each of the ten capsular serotypes described so far presents a unique chemical structure with distinct antigenic properties; therefore, broad protection against this pathogen could be achieved by a combination of ten glycoconjugates. Capsular polysaccharide biosynthesis and assembly follow a polymerase-dependent pathway that is widespread in encapsulated bacteria and is encoded by a polycistronic operon. Here we exploited the sequence similarity between the capsule operons of types V and IX to generate hybrid polysaccharides incorporating epitopes of both serotypes in a single molecule, by co-expressing their specific CpsM, O, I glycosyltransferases in a single isolate. Physicochemical and immunochemical methods confirmed that an engineered strain produced a high molecular weight chimeric polysaccharide, combining antigenic specificities of both type V and IX. By optimizing the copy number of key glycosyltransferase genes, we were able to modulate the ratio between type-specific epitopes. Finally, vaccination with chimeric glycoconjugates significantly decreased the incidence of disease in pups born from immunized mice challenged with either serotype. This study provides proof of concept for a new generation of glycoconjugate vaccines that combine the antigenic specificity of different polysaccharide variants in a single molecule, eliciting a protective immune response against multiple serotype variants.\n                  <\/jats:p>","DOI":"10.1007\/s10719-021-10000-4","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T03:03:35Z","timestamp":1620270215000},"page":"447-457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates"],"prefix":"10.1007","volume":"38","author":[{"given":"Edmondo","family":"Campisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Rosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evita","family":"Balducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Brogioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"De Ricco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Fabbrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Spagnuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliano","family":"Chiarot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immaculada","family":"Margarit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,6]]},"reference":[{"issue":"9146","key":"10000_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(98)07128-1","volume":"353","author":"a Schuchat","year":"1999","unstructured":"Schuchat, a: Group B streptococcus. Lancet 353(9146), 51\u201356 (1999)","journal-title":"Lancet"},{"issue":"1","key":"10000_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1365-2958.2004.04266.x","volume":"54","author":"KS Doran","year":"2004","unstructured":"Doran, K.S., Nizet, V.: Molecular pathogenesis of neonatal group B streptococcal infection: no longer in its infancy. Mol. Microbiol. 54(1), 23\u201331 (2004). https:\/\/doi.org\/10.1111\/j.1365-2958.2004.04266.x","journal-title":"Mol. Microbiol."},{"issue":"14","key":"10000_CR3","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1056\/NEJM197604012941404","volume":"294","author":"CJ Baker","year":"1976","unstructured":"Baker, C.J., Kasper, D.L.: Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N. Engl. J. Med. 294(14), 753\u2013756 (1976). https:\/\/doi.org\/10.1056\/NEJM197604012941404","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10000_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/2051013615579869","volume":"3","author":"A Nuccitelli","year":"2015","unstructured":"Nuccitelli, A., Rinaudo, C.D., Maione, D.: Group B Streptococcus vaccine: state of the art. Ther Adv Vaccines 3(3), 76\u201390 (2015). https:\/\/doi.org\/10.1177\/2051013615579869","journal-title":"Ther Adv Vaccines"},{"issue":"5","key":"10000_CR5","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1128\/IAI.73.5.3096-3103.2005","volume":"73","author":"MJ Cieslewicz","year":"2005","unstructured":"Cieslewicz, M.J., Chaffin, D., Glusman, G., Kasper, D., Madan, A., Rodrigues, S., Fahey, J., Wessels, M.R., Rubens, C.E.: Structural and genetic diversity of group B streptococcus capsular polysaccharides. Infect. Immun. 73(5), 3096\u20133103 (2005). https:\/\/doi.org\/10.1128\/IAI.73.5.3096-3103.2005","journal-title":"Infect. Immun."},{"issue":"9","key":"10000_CR6","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1128\/JCM.00117-07","volume":"45","author":"HC Slotved","year":"2007","unstructured":"Slotved, H.C., Kong, F., Lambertsen, L., Sauer, S., Gilbert, G.L.: Serotype IX, a Proposed New Streptococcus agalactiae Serotype. J. Clin. Microbiol. 45(9), 2929\u20132936 (2007). https:\/\/doi.org\/10.1128\/JCM.00117-07","journal-title":"J. Clin. Microbiol."},{"issue":"34","key":"10000_CR7","doi-asserted-by":"publisher","first-page":"23437","DOI":"10.1074\/jbc.M114.567974","volume":"289","author":"F Berti","year":"2014","unstructured":"Berti, F., Campisi, E., Toniolo, C., Morelli, L., Crotti, S., Rosini, R., Romano, M.R., Pinto, V., Brogioni, B., Torricelli, G., Janulczyk, R., Grandi, G., Margarit, I.: Structure of the type IX group B Streptococcus capsular polysaccharide and its evolutionary relationship with types V and VII. J. Biol. Chem. 289(34), 23437\u201323448 (2014). https:\/\/doi.org\/10.1074\/jbc.M114.567974","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10000_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/infdis\/171.2.513","volume":"171","author":"LH Harrison","year":"1995","unstructured":"Harrison, L.H., Dwyer, D.M., Johnson, J.A.: Emergence of serotype V group B streptococcal infection among infants and adults. J. Infect. Dis. 171(2), 513 (1995). https:\/\/doi.org\/10.1093\/infdis\/171.2.513","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10000_CR9","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3201\/eid1904.121572","volume":"19","author":"P Ferrieri","year":"2013","unstructured":"Ferrieri, P., Lynfield, R., Creti, R., Flores, A.E.: Serotype IV and invasive group B Streptococcus disease in neonates, Minnesota, USA, 2000\u20132010. Emerg Infect Dis 19(4), 551\u2013558 (2013). https:\/\/doi.org\/10.3201\/eid1904.121572","journal-title":"Emerg Infect Dis"},{"key":"10000_CR10","doi-asserted-by":"publisher","unstructured":"Murayama, S.Y., Seki, C., Sakata, H., Sunaoshi, K., Nakayama, E., Iwata, S., Sunakawa, K., Ubukata, K., Invasive Streptococcal Disease Working, G.: Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections. Antimicrob. Agents Chemother. 53(6), 2650\u20132653 (2009). https:\/\/doi.org\/10.1128\/AAC.01716-08","DOI":"10.1128\/AAC.01716-08"},{"key":"10000_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev.micro.62.081307.162944","volume":"65","author":"J Yother","year":"2011","unstructured":"Yother, J.: Capsules of Streptococcus pneumoniae and other bacteria: paradigms for polysaccharide biosynthesis and regulation. Annu. Rev. Microbiol. 65, 563\u2013581 (2011)","journal-title":"Annu. Rev. Microbiol."},{"key":"10000_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev.biochem.75.103004.142545","volume":"75","author":"C Whitfield","year":"2006","unstructured":"Whitfield, C.: Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu. Rev. Biochem. 75, 39\u201368 (2006)","journal-title":"Annu. Rev. Biochem."},{"issue":"5731","key":"10000_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1126\/science.1109869","volume":"309","author":"D Maione","year":"2005","unstructured":"Maione, D., Margarit, I., Rinaudo, C.D., Masignani, V., Mora, M., Scarselli, M., Tettelin, H., Brettoni, C., Iacobini, E.T., Rosini, R., D\u2019Agostino, N., Miorin, L., Buccato, S., Mariani, M., Galli, G., Nogarotto, R., Nardi-Dei, V., Vegni, F., Fraser, C., Mancuso, G., Teti, G., Madoff, L.C., Paoletti, L.C., Rappuoli, R., Kasper, D.L., Telford, J.L., Grandi, G.: Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science 309(5731), 148\u2013150 (2005). https:\/\/doi.org\/10.1126\/science.1109869","journal-title":"Science"},{"issue":"5","key":"10000_CR14","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1172\/JCI114858","volume":"86","author":"MR Wessels","year":"1990","unstructured":"Wessels, M.R., Paoletti, L.C., Kasper, D.L., DiFabio, J.L., Michon, F., Holme, K., Jennings, H.J.: Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. J. Clin. Invest. 86(5), 1428\u20131433 (1990). https:\/\/doi.org\/10.1172\/JCI114858","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10000_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.biologicals.2011.05.004","volume":"39","author":"M Broker","year":"2011","unstructured":"Broker, M., Costantino, P., DeTora, L., McIntosh, E.D., Rappuoli, R.: Biochemical and biological characteristics of cross-reacting material 197 CRM197, a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applications. Biologicals 39(4), 195\u2013204 (2011). https:\/\/doi.org\/10.1016\/j.biologicals.2011.05.004","journal-title":"Biologicals"},{"key":"10000_CR16","doi-asserted-by":"publisher","unstructured":"Carboni, F., Adamo, R., Fabbrini, M., De Ricco, R., Cattaneo, V., Brogioni, B., Veggi, D., Pinto, V., Passalacqua, I., Oldrini, D., Rappuoli, R., Malito, E., Margarit, I.y.R., Berti, F.: Structure of a protective epitope of group B < em > Streptococcus<\/em > type III capsular polysaccharide. Proc. Natl. Acad. Sci. 114(19), 5017\u20135022 (2017). https:\/\/doi.org\/10.1073\/pnas.1701885114","DOI":"10.1073\/pnas.1701885114"}],"container-title":["Glycoconjugate Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-021-10000-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10719-021-10000-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-021-10000-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T07:29:15Z","timestamp":1625556555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10719-021-10000-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10000"],"URL":"https:\/\/doi.org\/10.1007\/s10719-021-10000-4","relation":{},"ISSN":["0282-0080","1573-4986"],"issn-type":[{"value":"0282-0080","type":"print"},{"value":"1573-4986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,6]]},"assertion":[{"value":"5 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RR, MRP, EV, VP, BB, RDR, MF, AS, ECh, FB, and IM are employees of the GSK group of companies. EC, RR, MRR, FB, IM are listed as inventors on patents owned by the GSK group of companies. FB, IM, MF, MRR hold shares of the GSK group of companies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}